Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

BTAIQ holding history

BioXcel Therapeutics, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BTAIQ overviewAll 13F holders of BTAIQFull Q2 2026 holdings

Shares (Q2 2026)
90,300
Value
$127.3K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of BTAIQ by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202690,300$127.3K<0.1%00.0%UnchangedHolders
Q1 202690,300$121.0K<0.1%00.0%UnchangedHolders
Q4 202590,300$144.5K<0.1%−108,300−54.5%ReducedHolders
Q3 2025198,600$508.4K<0.1%+198,600NewHolders
Q2 20250$00.0%−11−100.0%Sold outHolders
Q1 202511$22<0.1%+11NewHolders
Q3 20240$00.0%−2,205,172−100.0%Sold outHolders
Q2 20242,205,172$2.82M<0.1%−288,944−11.6%ReducedHolders
Q1 20242,494,116$7.03M<0.1%−24,448−1.0%ReducedHolders
Q4 20232,518,564$7.43M<0.1%−182,163−6.7%ReducedHolders
Q3 20232,700,727$6.83M<0.1%−1,672,720−38.2%ReducedHolders
Q2 20234,373,447$29.1M<0.1%+96,754+2.3%AddedHolders
Q1 20234,276,693$79.8M<0.1%+73,257+1.7%AddedHolders
Q4 20224,203,436$90.3M<0.1%+5,811+0.1%AddedHolders
Q3 20224,197,625$49.6M<0.1%+2690.0%AddedHolders
Q2 20224,197,356$55.4M<0.1%+320.0%AddedHolders
Q1 20224,197,324$87.8M<0.1%+2750.0%AddedHolders
Q4 20214,197,049$85.3M<0.1%+411,665+10.9%AddedHolders
Q3 20213,785,384$114.9M<0.1%+670,571+21.5%AddedHolders
Q2 20213,114,813$90.5M<0.1%+884,970+39.7%AddedHolders
Q1 20212,229,843$96.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.